These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10585204)

  • 41. Surrogate docking: structure-based virtual screening at high throughput speed.
    Yoon S; Smellie A; Hartsough D; Filikov A
    J Comput Aided Mol Des; 2005 Jul; 19(7):483-97. PubMed ID: 16292613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Finding multiactivity substructures by mining databases of drug-like compounds.
    Sheridan RP
    J Chem Inf Comput Sci; 2003; 43(3):1037-50. PubMed ID: 12767163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lead-like, drug-like or "Pub-like": how different are they?
    Oprea TI; Allu TK; Fara DC; Rad RF; Ostopovici L; Bologa CG
    J Comput Aided Mol Des; 2007; 21(1-3):113-9. PubMed ID: 17333482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinatorial networks.
    Lobanov VS; Agrafiotis DK
    J Mol Graph Model; 2001; 19(6):571-8, 610-3. PubMed ID: 11552686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mapping in the CNS.
    Wong MG; Tehan BG; Lloyd EJ
    Curr Pharm Des; 2002; 8(17):1547-70. PubMed ID: 12052200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simple selection criteria for drug-like chemical matter.
    Muegge I; Heald SL; Brittelli D
    J Med Chem; 2001 Jun; 44(12):1841-6. PubMed ID: 11384230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes.
    Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP
    J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor.
    Han LY; Ma XH; Lin HH; Jia J; Zhu F; Xue Y; Li ZR; Cao ZW; Ji ZL; Chen YZ
    J Mol Graph Model; 2008 Jun; 26(8):1276-86. PubMed ID: 18218332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration.
    Panarese JD; Cho HP; Adams JJ; Nance KD; Garcia-Barrantes PM; Chang S; Morrison RD; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3822-5. PubMed ID: 27173801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping of the Available Chemical Space versus the Chemical Universe of Lead-Like Compounds.
    Lin A; Horvath D; Afonina V; Marcou G; Reymond JL; Varnek A
    ChemMedChem; 2018 Mar; 13(6):540-554. PubMed ID: 29154440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of classification methods for the prediction of activity in diverse chemical libraries.
    Dixon SL; Villar HO
    J Comput Aided Mol Des; 1999 Sep; 13(5):533-45. PubMed ID: 10483533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase.
    Xing L; Goulet R; Johnson K
    J Chem Inf Model; 2011 Jul; 51(7):1582-92. PubMed ID: 21615155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration.
    Clark DE
    J Pharm Sci; 1999 Aug; 88(8):815-21. PubMed ID: 10430548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examination of the computed molecular properties of compounds selected for clinical development.
    Blake JF
    Biotechniques; 2003 Jun; Suppl():16-20. PubMed ID: 12813900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT(3)A, Histamine H(1), and Histamine H(4) Receptors.
    Schultes S; Kooistra AJ; Vischer HF; Nijmeijer S; Haaksma EE; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1030-44. PubMed ID: 25815783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.
    Wager TT; Chandrasekaran RY; Hou X; Troutman MD; Verhoest PR; Villalobos A; Will Y
    ACS Chem Neurosci; 2010 Jun; 1(6):420-34. PubMed ID: 22778836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Data mining a small molecule drug screening representative subset from NIH PubChem.
    Xie XQ; Chen JZ
    J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.
    Li H; Yap CW; Ung CY; Xue Y; Cao ZW; Chen YZ
    J Chem Inf Model; 2005; 45(5):1376-84. PubMed ID: 16180914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.